Our Clinical Evidence

Geneoscopy’s research and development are changing the way we approach gastrointestinal health through advanced diagnostics

Publications

Publications

Manuscripts


Cost-effectiveness of novel noninvasive screening tests for colorectal neoplasia


Noninvasive Stool RNA Test Approximates Disease Activity in Patients With Crohn’s Disease


Analytical Validation of the Multitarget Stool RNA Test for Colorectal Cancer Screening


CRC-PREVENT: Multi-target Stool RNA Test for Colorectal Cancer Screening


Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasias in a Multicenter, Prospective, and Retrospective Cohort


Noninvasive Detection of High-Risk Adenomas Using Stool-Derived Eukaryotic RNA Sequences as Biomarkers


Posters

Development of a Second Generation Multi-Target Stool RNA Test (ColoSense 2.0) for Colorectal Cancer Screening


Stool-derived Eukaryotic RNA Assay Approximates Disease Activity Index and Predicts Therapeutic Response in Patients with Crohn’s Disease on Advanced Therapies


Stool-derived Eukaryotic RNA Biomarkers for Predicting Therapeutic Response and Monitoring Mucosal Healing for Patients with Inflammatory Bowel Disease


Cost Effectiveness Analysis of Novel RNA-Fit Test as a Strategy for CRC Screening in Average Risk U.S. Population


CRC-PREVENT: clinical validation study shows expedited and diverse recruitment for the non-invasive RNA-FIT test that can detect advanced colorectal neoplasia with high sensitivity


Prospective Study Using Virtual Enrollment to Access An RNA-FIT Assay for Non-invasive Detection of Colorectal Neoplasis